Abstract
Changes to Treatment and Outcomes in Patients with Type 2 Diabetes Initiating Injectable Therapy (CHOICE) is a European prospective, observational cohort study assessing time to, and factors associated with, a significant change in therapy after type 2 diabetes patients initiate their first injectable glucose-lowering therapy, and these patients' clinical outcomes over 24 months. The authors report baseline data and factors associated with the injectable treatment regimen.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Diabetes Therapy |
Vol/bind | 3 |
Udgave nummer | 1 |
Sider (fra-til) | 6 |
ISSN | 1869-6953 |
DOI | |
Status | Udgivet - 2012 |